SCHEMBL975593

SCHEMBL975593

COC(=O)c1sc2ccccc2c1-c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.69
MAPK1 P28482 1/20 0.69
ALDH1A1 P00352 5/20 0.63
MAPT P10636 4/20 0.63
KDM4E B2RXH2 3/20 0.63
ATM Q13315 2/20 0.63
HSD17B10 Q99714 2/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
GLA P06280 1/20 0.63
GAA P10253 1/20 0.63
HPGD P15428 1/20 0.63
ALOX15 P16050 1/20 0.63
PLA2G1B P04054 1/20 0.52
ATG4B Q9Y4P1 1/20 0.52
L3MBTL1 Q9Y468 4/20 0.51
TDP1 Q9NUW8 2/20 0.51
TSHR P16473 1/20 0.50
TRPM8 Q7Z2W7 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68469 0.83 PLA2G1B (0.60) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL14615113 0.83 ALDH1A1 (0.49) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL11624275 0.83 LMNA (0.52) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL2506707 0.82 LMNA (0.49) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL9495325 0.82 LMNA (1.00) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL2958622 0.82 MCL1 (0.61) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL25203083 0.81 ALDH1A1 (0.53) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL5425424 0.80 LMNA (0.56) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL12922067 0.79 HDAC1 (0.62) LMNAMAPK1ALDH1A1MAPTKDM4E
SCHEMBL9495317 0.79 LMNA (0.82) LMNAMAPK1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107849035-B Phenyl heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2021-12-10 CN disclosed
US-9955689-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-01 US disclosed
US-9955689-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-01 US disclosed
US-9955689-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-01 US disclosed
CN-107849035-A Phenyl heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2018-03-27 CN disclosed
US-9894901-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
US-9894901-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
US-9894901-B2 Method for promoting plant growth SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-20 US disclosed
WO-2017114377-A1 BENZYL HETEROCYCLIC COMPOUND DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF 四川海思科制药有限公司 2017-07-06 WO disclosed
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-15 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2014-02-13 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed
EP-2217588-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2010-08-18 EP disclosed
WO-2009055917-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-05-07 WO disclosed
WO-2009055917-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-05-07 WO disclosed
US-4122034-A 2-AMINO-3-ARYL-HETEROINDENES SCHERING CORPORATION (US) 1978-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 LMNA 357/4885MAPK1 3439/4885ALDH1A1 699/4885
US-20150289506-A1 METHOD FOR PROMOTING PLANT GROWTH FGF2, BROX, BOLA2; BOLA2B LMNA 4787/4885MAPK1 1018/4885ALDH1A1 775/4885
US-20140045850-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 LMNA 357/4885MAPK1 3439/4885ALDH1A1 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.